Further statistical analysis showed significant differences among subgroups of T2DM patients without CAD and those with CAD (classified into three subgroups based on the stage of CAD), as well as the healthy individuals, concerning the following clinical and laboratory parameters: age, blood glucose concentration, HbA1c, systolic and diastolic blood pressure (SBP, DBP), total cholesterol, triglycerides, LDL cholesterol, CRP, and Lp-PLA2. The gene discussed is PLA2G7; the disease is type 2 diabetes mellitus.